Q3 2017

Filed Nov 8, 2017 · 10-Q · 39 days after period end · 0000877860-17-000087

Q3 2017 · 10-Q

Revenue

$71.35M

+12.8% vs Q3 2016

Net Income

$39.09M

+18.3% vs Q3 2016

EPS Diluted

$0.94

+13.3% vs Q3 2016

Operating Income$39,092,000+16.8%

Operating Cash Flow

Same quarter

Metric	Q3 2017	Q3 2016	Q3 2015	Q3 2014
Revenue	$71.35M	$63.25M	$58.28M	$44.48M
Net Income	$39.09M	$33.03M	$33.60M	$25.25M
EPS Diluted	$0.94	$0.83	$0.89	$0.76

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR